A new single cell detection technology allows simultaneous measurement of up to 100 surface markers and signaling proteins of immune cells. This method provides the opportunity to make great advances into the scientific understanding of rheumatic disease and the provision of individualized patient care.
Change history
01 October 2012
In the version of this article initially published in print and online, the author did not include an acknowledgement of grant support as required by his funding policy. This omission has been corrected for the HTML and PDF versions of the article.
References
Bendall, S. C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687–696 (2011).
Crow, M. K. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res. Ther. 12 (Suppl. 1), S5 (2010).
Obermoser, G. & Pascual, V. The interferon-α signature of systemic lupus erythematosus. Lupus 19, 1012–1019 (2010).
Lande, R. et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011).
Balboni, I. et al. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu. Rev. Immunol. 24, 391–418 (2006).
Silverman, G. J. et al. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin. Exp. Immunol. 153, 102–116 (2008).
Graham, R. R. et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38, 550–555 (2006).
Bauer, J. W. et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 3, e491 (2006).
Bauer, J. W. et al. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum. 60, 3098–3107 (2009).
Acknowledgements
P. J. Utz was the recipient of a Donald E. and Delia B. Baxter Foundation Career Development Award and his work is supported by National Heart, Lung, and Blood Institute (NHLBI) Proteomics contract HHSN288201000034C, Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension, NIH grants 5 U19-AI082719, 5 U19-AI050864, 5 U19-AI056363, 1 U19 AI090019 and 4 U19 AI090019, Canadian Institutes of Health Research grant 2 OR-92141, Alliance for Lupus Research grant number 21858, a gift from the Ben May Trust and a gift from the Floren Family Trust, and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 261382.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Cheung, R., Utz, P. CyTOF—the next generation of cell detection. Nat Rev Rheumatol 7, 502–503 (2011). https://doi.org/10.1038/nrrheum.2011.110
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2011.110
- Springer Nature Limited
This article is cited by
-
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia
Nature Cancer (2021)
-
Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysis
BMC Cancer (2020)
-
Mass cytometry analysis of immune cells in the brain
Nature Protocols (2018)
-
Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization
Analytical and Bioanalytical Chemistry (2017)
-
Correction: Screening: CyTOF—the next generation of cell detection
Nature Reviews Rheumatology (2012)